Vimarsana
Biggest News Aggregation in the World

Page 4 - Cm Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Life Sciences Today - Breaking & Trending Today

Ex-Rich Lister Robert Bates' ousted from wellness start-up Aurum+ as co-founder Charles Akle pays bills from his own pocket - Vimarsana News

Ex-Rich Lister Robert Bates' ousted from wellness start-up Aurum+ as co-founder Charles Akle pays bills from his own pocket

Mr Bates is facing allegations from high net worth investors that he failed to issue shares in Aurum+, despite claiming to have raised $15 million in investor capital.

Source: afr.com
(SPAC) Special Purpose Acquisition Investigation: SMFR, - Vimarsana News

(SPAC) Special Purpose Acquisition Investigation: SMFR,

SAN DIEGO, Jan. 14, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection...

Recent Investment Analysts' Ratings Updates for Sema4 (SMFR) - Vimarsana News

Recent Investment Analysts' Ratings Updates for Sema4 (SMFR)

A number of firms have modified their ratings and price targets on shares of Sema4 (NASDAQ: SMFR) recently: 6/2/2022 – Sema4 is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $3.50 price target on the stock. 5/25/2022 – Sema4 was upgraded by analysts at Zacks Investment […]

Research Analysts' Upgrades for May 24th (ACET, ASMB, CDZI, CWCO, DNLMY, DOCS, DSRLF, EDR, EME, EQRX) - Vimarsana News

Research Analysts' Upgrades for May 24th (ACET, ASMB, CDZI, CWCO, DNLMY, DOCS, DSRLF, EDR, EME, EQRX)

Research Analysts’ upgrades for Tuesday, May 24th: Adicet Bio (NASDAQ:ACET) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Assembly Biosciences (NASDAQ:ASMB) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Cadiz (NASDAQ:CDZI) was upgraded by analysts at StockNews.com to a sell rating. Consolidated Water […]

EQRx (NASDAQ:EQRX) Upgraded to "Buy" by Zacks Investment Research - Vimarsana News

EQRx (NASDAQ:EQRX) Upgraded to "Buy" by Zacks Investment Research

EQRx (NASDAQ:EQRX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. The firm presently has a $4.75 price target on the stock. Zacks Investment Research‘s price target points to a potential upside of 10.47% […]